Rankia México Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia España Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14,038 / 16,979
#112297

Re: Farmas USA

mola la bitbucket !

#112298

Re: Farmas USA

Over 1,000 stocks now have an RSI hovering at 30.  Over 2,400 stocks have an RSI less than 40. $CELG is at 28. $AAPL RSI = 31. So oversold!

#112299

Re: Farmas USA

EXEL

Aprobación en UE para HCC

Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) Tablets for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib

– EC approval triggers $40 million milestone payment to Exelixis under Collaboration Agreement with Ipsen –

– Exelixis’ supplemental New Drug Application for CABOMETYX for previously treated advanced HCC currently in review with the U.S. Food and Drug Administration –

http://ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2377258

#112300

Re: Farmas USA

A comprar como posesos . hahahaha

#112301

Re: Farmas USA

Vamooooooossss!!! Capaces son de cascarle otro -5%

EXEL

#112302

Re: Farmas USA

Igual "la subida" fue ayer, que con la que caía se mantuvo en verde...

Por cierto, se han largado los Baker Bros, sold out. 510k cromos

Veo que han aumentado en ACAD 1,2mill de acc y en NVAX le han metido 4,7 mill de cromos a la saca. Hoy último día para dar a conocer los movimientos de Q3 de los Institucionales.

#112304

Re: Farmas USA

ARNA

 

Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag

 

- Arena will receive $800M upfront, and is eligible to receive low double-digit tiered royalties, plus up to $400M in milestone payments
- United Therapeutics will receive exclusive, worldwide rights to ralinepag - a potential best-in-class agent for the treatment of pulmonary arterial hypertension
- Arena to host conference call and webcast today at 8:30

http://invest.arenapharm.com/news-releases/news-release-details/arena-pharmaceuticals-and-united-therapeutics-announce-global